September 21 - 23, 2016
Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM
Keynote Speaker: Lawrence D. Mayer (Jazz Pharmaceuticals)
Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.
September 30 - October 1, 2015
Keynote Speakers: Ian Ferguson (ARM), Christian Stammel (Wearable Technologies AG)
Continuous health monitoring using wearable sensors, mobile devices, and apps is becoming a powerful tool for assessing critical physiological parameters. The vast accumulation of real-time biometric data obtained from these technologies may hold invaluable clues for treating some of the most devastating human diseases.
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
June 11 - 13, 2013
Organizers: Mark E. Davis (California Institute of Technology, Pasadena), Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School), Brooke Grindlinger (The New York Academy of Sciences), Melanie Brickman Stynes (The New York Academy of Sciences), Roger Kornberg (Stanford University School of Medicine), Robert S. Langer (Massachusetts Institute of Technology), Konstantin Severinov (Rutgers the State University of New Jersey)
Throughout the past decade nanoparticles, and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies. This conference will discuss: nanodiagnostics for cancer biomarkers and imaging, toxicity and safety; nanovaccines and nanoimmunotherapeutics; targeted delivery in tumors; and nanoparticle-based gene therapy.
Friday, November 16, 2012 | 9:00 AM - 4:30 PM
Keynote Speakers: KC Huang (Stanford University), Amir Yacoby (Harvard University)
Speakers: Yanan Geng (Rutgers University), Matt Lohr (The University of Pennsylvania), Siarhei Samsonau (College of Staten Island), Carl Schreck (Yale University), Heli Vora (Stony Brook University), Scott Dietrich (City College of New York)
Moderator and Panelists: Seth Pinsky (NYC Economic Development Corporation), Shelley A. Harrison (Executive-in-Residence, NYU Center for Urban Science and Progress), Kathleen R. McKeown (Institute for Data Sciences and Engineering, Columbia University), Michael O'Boyle (IBM)
This biannual condensed matter physics conference features keynote talks in hard matter and soft matter as well as a series of student presentations. There will also be a special panel discussion, "Generation Tech: Tapping NYC's Science & Engineering Talent," moderated by Seth Pinsky, President of the NYC Economic Development Corp, and featuring representatives of the new engineering and applied science institutions that are being created in the city.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents four reports: (1) Alzheimer's Disease Research and Development: a Call for a New Research Roadmap; (2) Economic Analysis of Opportunities to Accelerate Alzheimer's Disease Research and Development; (3) Nanomedicines: Addressing the Scientific and Regulatory Gap; and (4) The Science and Policy of Critical Loads of Pollutant Deposition to Protect Ecosystems in New York.
Organizers: Raj Bawa (Bawa Biotech LLC; Rensselaer Polytechnic Institute), Scott E. McNeil
(Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd.; University of Basel, Switzerland), Melanie Brickman Stynes (The New York Academy of Sciences), and Melinda Miller (The New York Academy of Sciences)
Keynote Speaker: Sally Tinkle (Science and Technology Policy Institute, IDA)
This eBriefing explores regulatory challenges in the nascent field of nanomedicines.
Keynote Speakers: Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School) and Ralph Weissleder (Massachusetts General Hospital)
This eBriefing discusses nanoparticles, which have recently emerged at the forefront of cancer therapies, highlighting their uses in cancer diagnosis, treatment, and prevention.
Keynote Speakers: KC Huang (Stanford University) and Amir Yacoby (Harvard University)
Panel Moderator: Seth Pinsky (NYC Economic Development Corporation)
This eBriefing documents the 8th condensed matter physics conference featuring keynote talks in hard matter and soft matter as well as a special panel discussion, "Generation Tech: Tapping NYC's Science & Engineering Talent," featuring representatives of the new engineering and applied science institutions that are being created in the city.